Drug price control in Malaysia: a stakeholder analysis

Author:

Ashraf AmirulORCID,Ong Siew ChinORCID

Abstract

PurposePharmaceutical pricing has always been a contentious issue around the world. Recently, the Government of Malaysia has proposed for drug price control. This proposal has received backlash from pharmaceutical industry. Therefore in this study, the authors would like to examine the position of various stakeholders on this issue.Design/methodology/approachThe authors used Policy Maker software to identify and evaluate the position of the stakeholders, their interest and their power. Next, the authors contextualize the factors that might contribute to the success or failure of the policy using Kingdon's multiple stream analysis.FindingsThe authors found that the drug price control regulation received mixed reactions from the stakeholders, with the public sector mainly supporting the proposal whereas the private sectors opposing it. The findings indicate that the drug price control proposal have a high chance of success due to strong political will from both the government and the opposition and also strong support from the public and the consumer groups.Practical implications1. The drug price control proposal received strong political will and strong public support. Thus, it has a high chance of success. 2. The government should be careful in managing concentrated powerful groups. The government should strategically engage with the stakeholders to move them to more positive attitude. 3. The government should avoid backtracking on policies as this will portray critical weakness to other stakeholders.Social implicationsThe public sector provides strong support for the regulation. However, this support must be maintained and remain as their top priority. Their opinions are important in shaping health policies. The public's feedback will provide transparency and accountability in the policy-making process.Originality/valueThe findings indicate that the drug price control proposal have a high chance of success due to strong political will from both the government and the opposition and also strong support from the public and the consumer groups.

Publisher

Emerald

Subject

Health Policy,Business, Management and Accounting (miscellaneous)

Reference46 articles.

1. Pelobian Polisi Awam: Pengaruh Gabungan Persatuan-persatuan Pengguna Malaysia (FOMCA) sebagai Kumpulan Pendesak;Jurnal Komunikasi: Malaysian Journal of Communication,2003

2. Affordability of essential medicine prices in Malaysia's private health sector;Patient Prefer Adherence,2018

3. Babar, Z.U.D., Ibrahim, M.I.M., Singh, H., Bukahri, N.I. and Creese, A. (2007), “Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia”, in Harvey, K. (Ed.), PLoS Med, [Internet], Vol. 4 No. 3, p. e82, available at: https://dx.plos.org/10.1371/journal.pmed.0040082.

4. High drug prices: so who is to blame?;Hospital Pharmacy,2017

5. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon's multiple streams framework;Health Research Policy and System,2019

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3